Aberrant intracellular localisation of PRH and/or altered PRH levels have been observed in a number of disease states including breast and thyroid cancer.10, 11 This suggests that loss or reduction of PRH activity is associated with the increased proliferation of breast and thyroid cancer cells. Here, HHEX is linked to thyroid cancer.